08:28 AM EDT, 07/29/2025 (MT Newswires) -- Novo Nordisk ( NVO ) reported Q2 earnings Tuesday of 5.96 Danish krone ($0.92) per diluted share.
Analysts polled by FactSet expected 6.04 Danish krone per share.
Sales for the quarter grew 18% at a constant exchange rate, the company said.
Novo Nordisk ( NVO ) said it expects fiscal 2025 operating profit to grow 10% to 16%, down from its prior guidance of 16% to 24%.
The company expects fiscal 2025 sales growth of 8% to 14%, down from its prior expectation of 13% to 21% growth.
Novo Nordisk ( NVO ) shares were down by nearly 20% in recent premarket activity.